Kalle Känd
Feusisberg
Chairperson of the board
Joint signing authority (any two to sign)
Stefan Busemann
München, DE
Member of the board
Joint signing authority (any two to sign)
Markus Unger
Widen
Member of the board
Joint signing authority (any two to sign)
Michael Thuy
Stallikon
Member of the board
Joint signing authority (any two to sign)
Rami Al Khayyat
Amman
Member of the board
Individual signing authority
Adam Dimitropoulos
Küssnacht
Member of the board
Joint signing authority (any two to sign)
Michael Thuy
Steinhausen
Member of the board
Joint signing authority (any two to sign)
Building smart people network graph...
Fetching people and their companies
Primary Address
Loading map...
| No. | Journal No. | Journal date | SOGC | SOGC date | Page / ID |
|---|---|---|---|---|---|
| 1 | 21499 | 25.11.2025 | 1006497487 | 28.11.2025 | 1006497487 |
| 2 | R22252 | 30.12.2024 | 1006220890 | 06.01.2025 | 1006220890 |
| 3 | 20802 | 06.12.2024 | 1006201434 | 11.12.2024 | 1006201434 |
| 4 | 7035 | 05.05.2023 | 1005742781 | 10.05.2023 | 1005742781 |
| 5 | 12563 | 09.09.2020 | 1004977897 | 14.09.2020 | 1004977897 |
| 6 | 341 | 09.01.2020 | 1004803873 | 14.01.2020 | 1004803873 |
Steuerung der globalen Aktivitäten der MS Pharma Gruppe und Investition in andere Unternehmen, insbesondere in chemische und pharmazeutische Unternehmen, Verwertung von Patenten und anderen Rechte des geistigen Eigentums sowie Abwicklung aller Arten von Handelsgeschäften; vollständige Zweckumschreibung gemäss Statuten
